risankizumab,tofacitinib,vedolizumab,azacitidine,ustekinumab,ozanimod,upadacitinib,adalimumab,golimumab,infliximab
abbvie,bms,janssen,takeda,pfizer
[]
 really interesting slides. is there evidence for the above / below 60 years in terms of safety and choice of agent?
Husband & Dad (@DisneyLauren). Gastroenterologist. @thebowelgroup board, @midsgastrosoc secretary, WM education. RT?endorsement. #DGBI #IBD #GIB